It currently is very cheap for an entity to keep IPIX share
It currently is very cheap for an entity to keep IPIX share price down based on the current 11 cent or so share price. Take an example where a manipulator has a $27,500 daily bank-roll to buy up to 250,000 shares. For this example let’s say they are willing to take a half a cent loss on their transactions to keep the stock artificially low. A half cent loss currently represents 5% of the total share price and on 250,000 shares is only $1,250. That $1,250 daily loss is probably less expensive than what they are paying their paid bashers on a daily basis. The only reason they have to take this minor loss is that there are still some pesky longs that keep nibbling away at these depressed values. Both the paid bashers and the daily transaction hits are simply the price of poker to them.
Now let’s use the same example and we wake up some morning soon and the share price has spiked up to $3.00/share after a partnership announcement. There is an abundance of NEW buyers beyond the pesky longs that have been holding on for dear life. These new buyers drive REAL volume up to levels that we have previously never seen on IPIX as the entire biotech, pharmaceutical and Wall Street industries take notice and buy their tickets for a piece of a rising biotech star.
Back to our manipulator. That same $27,500 bank-roll would now only buy 9,166 shares vs the 250,000 shares currently. 9,166 shares will be a rounding error if legit volume raises to 500,000 to 1M shares daily. To control that same 5% of overall share price at $3 as the example above the manipulator would now have to take a daily hit of 15 cents vs a half a cent per share. A 15 cent loss on the same 250,000 shares would now be $37,500 loss per day vs only $1,250 currently. The cost of poker has just significantly gone up for the manipulator. The manipulator knows that $3/share is just the start as many of the new investors are just as pesky as the current longs and are looking for $10-$20/share exit strategies as Brilacidin and Kevetrin advance to market.
At some point the law of supply and demand wins. It always does.
11
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Compassionate Expansion Reflecting Community Needs You talk to just about any family facing the heart-wrenching task of making decisions for a loved one's final farewell, and the story ain't pretty. Pricey packages, pressure to upgrade, and a constant side-eye wondering if they're getting the real deal. For Minnesota Cremation Services, though, this expansion is about...
Continue Reading
Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...
Continue Reading
A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...
Continue Reading
Change Is Coming to the Las Vegas Strip Las Vegas is about to shake things up in a way not seen for six long decades. Yep, they're breaking ground on a brand new intersection on the Strip! You heard me right—Russell Road and Las Vegas Boulevard are getting some fresh asphalt, thanks to the backing of State Senator Fabian Doñate and Assemblymember Cecelia González....
Continue Reading
Taking Energy Storage to New Heights in Australia Sometimes, the energy game looks like a mess of mismatched puzzle pieces, but every now and then, the pieces align perfectly. Here’s Rondo Energy, paired up with Rio Tinto, diving nose-first into a whopper of a project in Gladstone. We’re talking about the largest thermal energy storage undertaking in Australia, a big...
Continue Reading
California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...
Continue Reading
Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...
Continue Reading
Strategic Moves in a Challenging Market When it rains, it pours. Ashford Hospitality Trust (NYSE: AHT), the real estate investment trust that's got its fingers in the hotel industry pie, is shaking things up with some bold maneuvers. The company just dropped a bombshell: it's waiving a $17 million advisory fee, buying back shares, and terminating its at-the-market (ATM)...
Continue Reading
Home Remodeling: More Than Just a Facelift Ah, the prospect of turning your house into your dream home—sounds idyllic until you're knee-deep in dusty chaos. Remodeling isn't a walk in the park; it's a marathon filled with pitfalls and rollercoaster emotions. According to Brian Ward from Ward Construction & Remodeling, the process has set stages, and knowing these can...
Continue Reading
A Cold Shower for Millrose Properties' Investors Investing in Millrose Properties, Inc. (NYSE: MRP) didn't quite pan out as some folks hoped. On the heels of Hunterbrook's report about dubious deals, the Company's stock tumbled 8.53%, smacking investors with a not-so-gentle reminder of market realities. Sure, stocks can dip and dive like a rollercoaster, but when it...
Continue Reading
Top 5 Most Recently Viewed Articles
United Development Funding IV Announces Cash Distribution In an important update, United Development Funding IV has made an announcement regarding a cash distribution to its shareholders. The board of trustees authorized a crucial cash distribution of $2.3785 per share, reflecting great value and consideration for its investors. Shareholders of record on a specified date...
Continue Reading
Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...
Continue Reading
Solowin Holdings: A Key Player in the Evolving Crypto Market As the global crypto-finance landscape continues to change, many companies are adjusting their strategies to take advantage of the new opportunities that emerge. Solowin Holdings (NASDAQ: SWIN) is an exemplary case, embracing this transformation wholeheartedly. With their innovative approach and comprehensive...
Continue Reading
Understanding the Class Action Lawsuit Against lululemon In a significant development for investors of lululemon athletica inc., a securities class action lawsuit has recently been initiated. This lawsuit arises from alleged misstatements and the failure to disclose crucial information during a specific time frame. Investors who had purchased or acquired lululemon...
Continue Reading
22nd Century Group Faces Market Challenges Recently, 22nd Century Group, Inc. (NASDAQ: XXII) experienced a major setback as its stock price fell to a 52-week low of $0.25. This sharp decline mirrors a broader trend over the last year, resulting in a staggering 98.6% loss in value. Investors are understandably anxious as the company seeks to stabilize its stock price amid...
Continue Reading
